Evidence map›Paper›PMID 42202908›Full record

ReviewThe journal of allergy and clinical immunology. In practice2026

Risk Factors for Secondary Immunodeficiency in the Aged.

Anna Lang, Alexandros Grammatikos, Mark Ballow, Iris Otani, Sara Barmettler

Abstract readReview
In one paragraph

Review in The journal of allergy and clinical immunology. In practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Anna LangDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, UCSF Medical Center, San Francisco, Calif.
Alexandros GrammatikosBristol NHS Immunology Allergy Centre, Southmead Hospital, Bristol, United Kingdom.
Mark BallowDivision of Allergy and Immunology, Department of Pediatrics, Morsani College of Medicine, University of South Florida, St Petersburg, Fla.
Iris OtaniDivision of Pulmonary, Critical Care, Allergy, and Sleep Medicine, UCSF Medical Center, San Francisco, Calif.
Sara BarmettlerDivision of Allergy and Clinical Immunology, Department of Medicine, Massachusetts General Hospital, Boston, Mass; Harvard Medical School, Boston, Mass. Electronic address: sbarmettler@mgh.harvard.edu.

Funding

Modeling Risk for Hypogammaglobulinemia, Infections, and Mortality with Chimeric Antigen Receptor (CAR) T-cell TherapyK23AI163350 · NIAID · MASSACHUSETTS GENERAL HOSPITAL · PI BARMETTLER, SARA · 2021 to 2025
$1.1M
NIAID NIH HHS K23 AI163350
6 · The paper itself

Abstract

Secondary immune deficiencies, in which the immune system is weakened or compromised by another factor, have become prevalent. Secondary immune deficiencies are particularly pertinent in aged people because numerous etiologies cause immune dysfunction in this population. Immunosenescence is characterized by inflammaging, cellular senescence, thymic involution, reduced naive T- and B-cell output, restricted antigen receptor diversity, and impaired innate immune cell function, leading to increased susceptibility to infection and diminished vaccine responsiveness. Malnutrition is common in aged people and exacerbates immune dysfunction through impaired cell-mediated immunity, micronutrient deficiencies, and weakened mucosal barriers. Immunosuppressive therapies are also frequently used in older adults, such as corticosteroids, cytotoxic agents, purine analogs, and biologics. Other comorbidities such as chronic kidney and liver disease, diabetes, cardiovascular disease, chronic lung disease, and persistent viral infections also contribute to immune dysregulation. Given these cumulative risks, vaccination remains a cornerstone of prevention. Updated immunization strategies targeting COVID-19, influenza, respiratory syncytial virus, herpes zoster, and pneumococcal disease are critical to reducing morbidity and mortality in this vulnerable population.

Indexed as

AgingImmunologic Deficiency SyndromesCOVID-19HumansImmunosenescenceImmunosuppressive AgentsMalnutritionRisk FactorsSARS-CoV-2VaccinationImmunosuppressive AgentsAgedChronic diseaseElderlyImmune effectImmunodeficiencyImmunosenescenceMalnutritionMedication effectSecondary immune deficiencyVaccination

Identifiers

PMID42202908
PMCPMC13284793

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.